Myriad Genetics
MYGN
MYGN
252 hedge funds and large institutions have $2.5B invested in Myriad Genetics in 2016 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 91 increasing their positions, 83 reducing their positions, and 25 closing their positions.
Holders
252
Holders Change
+19
Holders Change %
+8.15%
% of All Funds
6.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
46
Increased
91
Reduced
83
Closed
25
Calls
$8.7M
Puts
$26.4M
Net Calls
-$17.7M
Net Calls Change
-$8.69M
Top Buyers
1 |
EA
1
Emerald Acquisition
Seattle,
Washington
|
$27.3M |
2 |
2
Goldman Sachs
New York
|
$30.3M |
3 |
3
Morgan Stanley
New York
|
$39M |
4 |
RHJA
4
Rice Hall James & Associates
San Diego,
California
|
$16.1M |
5 |
5
Millennium Management
New York
|
$24.5M |